Squarepoint’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,265
| Closed | -$47K | – | 2690 |
|
|
2022
Q2 | $47K | Buy |
+11,265
| New | +$47K | ﹤0.01% | 1962 |
|
|
2021
Q4 | – | Sell |
-27,233
| Closed | -$89K | – | 2937 |
|
|
2021
Q3 | $89K | Sell |
27,233
-16,236
| -37% | -$53.1K | ﹤0.01% | 2029 |
|
|
2021
Q2 | $183K | Buy |
43,469
+5,557
| +15% | +$23.4K | ﹤0.01% | 2268 |
|
|
2021
Q1 | $189K | Buy |
+37,912
| New | +$189K | ﹤0.01% | 2174 |
|
|
2020
Q4 | – | Sell |
-20,393
| Closed | -$200K | – | 2987 |
|
|
2020
Q3 | $200K | Buy |
+20,393
| New | +$200K | ﹤0.01% | 1937 |
|
|
2020
Q2 | – | Sell |
-42,469
| Closed | -$375K | – | 2531 |
|
|
2020
Q1 | $375K | Sell |
42,469
-18,058
| -30% | -$159K | 0.01% | 1185 |
|
|
2019
Q4 | $558K | Sell |
60,527
-4,673
| -7% | -$43.1K | ﹤0.01% | 1667 |
|
|
2019
Q3 | $383K | Buy |
65,200
+44,104
| +209% | +$259K | ﹤0.01% | 1694 |
|
|
2019
Q2 | $253K | Buy |
21,096
+3,170
| +18% | +$38K | ﹤0.01% | 1935 |
|
|
2019
Q1 | $216K | Buy |
+17,926
| New | +$216K | ﹤0.01% | 1872 |
|
|
2018
Q4 | – | Sell |
-42,200
| Closed | -$626K | – | 2311 |
|
|
2018
Q3 | $626K | Buy |
42,200
+3,500
| +9% | +$51.9K | 0.01% | 1202 |
|
|
2018
Q2 | $651K | Buy |
38,700
+15,464
| +67% | +$260K | 0.01% | 1069 |
|
|
2018
Q1 | $532K | Buy |
23,236
+3,973
| +21% | +$91K | 0.01% | 1068 |
|
|
2017
Q4 | $498K | Sell |
19,263
-2,237
| -10% | -$57.8K | 0.01% | 1207 |
|
|
2017
Q3 | $317K | Buy |
21,500
+5,100
| +31% | +$75.2K | 0.01% | 1140 |
|
|
2017
Q2 | $229K | Buy |
16,400
+2,636
| +19% | +$36.8K | ﹤0.01% | 1245 |
|
|
2017
Q1 | $235K | Sell |
13,764
-21,561
| -61% | -$368K | 0.01% | 1199 |
|
|
2016
Q4 | $363K | Buy |
+35,325
| New | +$363K | 0.01% | 1028 |
|